What is Lavomax

Posted on by admin

Lavomax

- "Flucomazole" 1 tab - at the beginning of treatment, 1 tab - after a week.

— candles “Neo Penotran N 14” — 1 stick each. at night - 10 days;

- then, Genferon candles - 1 stick each. at night - 10 days;

— to my husband “Lavomax” according to the scheme.

Table of contents:

Question: How to take all this at the same time? Vilprafen + Trichopolum + Flucomazole + suppositories? Or first some tablets for 10 days, then another 10 days, and then, after the tablets, suppositories? And if my period starts, and I don’t have time to put all the candles in, then after my period, can the treatment be continued? Please answer, I can’t contact my doctor! Thanks in advance!

vilprafen and Corsil, you can take them together. They are strong

affect the body?

Karsil is taken before meals.

Lavomax - after meals.

The doctor prescribed medication:

Lavomax N10 (0.125): in the first two days, 1 tablet,

then 1 table. in one day,

Unidox N10 (0.1): 1 dose - 2 tablets, then 1 tablet. (Isn't it enough?

The instructions from the doctor say 2 tablets every day.)

Azicide N6 (0.25): 1 dose 0.5 (2 tablets) then 1 tablet.

Could you tell me how to take Levomax and Unidox?

alternate them or drink each medicine completely

separately. And what can be replaced.

Thank you in advance!

Question about LAVOMAX.

My son is 4.5 years old. Is it possible to give him Lavomax, but in reduced doses?

The information provided is intended for medical and pharmaceutical professionals, should not be used for treatment and cannot be considered as official. The most accurate information about the drug is contained in the instructions supplied with the packaging by the manufacturer. No information posted on this or any other page of our website can serve as a substitute for personal contact with a specialist.

Please pay attention to the specified dates for entering information; information may become outdated.

Source: http://www.webapteka.ru/drugbase/name17456.html

Lavomax

Description current as of 02/24/2016

  • Latin name: Lavomax
  • ATX code: L03AX
  • Active ingredient: Tilorone
  • Manufacturer: NIZHFARM (Russia)

Compound

Lavomax contains tilorone dihydrochloride as an active substance, and additional components: calcium stearate, magnesium hydroxycarbonate pentahydrate, povidone.

The shell consists of povidone, sucrose, copovidone, magnesium hydroxycarbonate pentahydrate, colloidal silicon dioxide, titanium dioxide, macrogol 6000, liquid paraffin, beeswax, talc, dye.

Release form

This medicine is produced in the form of yellow or orange coated tablets. The core is orange. The tablets are round. The contour package can contain 3, 4, 6 or 10 tablets.

pharmachologic effect

Lavomax tablets have an immunomodulatory and antiviral effect.

The active component stimulates the production of interferons in the body. After the administration of Lavomax, interferon is produced mainly by hepatocytes, intestinal epithelial cells, neutrophils, and T-lymphocytes.

After the antiviral drug Lavomax has been taken orally, the highest degree of interferon production occurs as follows: intestines-liver-blood. This process begins after 4-24 hours. Under its influence, brain stem cells are stimulated, antibodies are formed, and the degree of immunosuppression is reduced. There is also a restoration of the T-helper/T-suppressor ratio.

The mechanism of its influence is associated with the process of inhibiting the translation of virus-specific proteins in those cells that have been infected. As a result, viral reproduction is suppressed.

Pharmacokinetics and pharmacodynamics

After the drug has been taken orally, the substance tilorone is quickly absorbed from the digestive tract. Bioavailability is 60%. Approximately 80% binds to blood proteins.

The active component does not undergo biotransformation and does not accumulate in the body. Most of it is excreted unchanged in feces (approximately 70%), a small part is excreted in urine (approximately 9%). Half-life is 48 hours.

Indications for use

The instructions for the drug define the following indications for the use of Lavomax in adult patients:

Lavomax is used as part of complex treatment.

Contraindications

Before taking Lavomax, you should take into account the contraindications that are indicated in the instructions for the medicine. These are:

Side effects

While taking the pills, the following side effects may occur:

Lavomax tablets, instructions for use

According to the instructions for use of Lavomax, the tablets should be taken after meals.

Patients with influenza and ARVI are prescribed 125 mg of Lavomax in the first 2 days, then 125 mg every other day. A total dose of 750 mg is used throughout the course of treatment.

To prevent influenza and ARVI, you need to take 125 mg of Lavomax once a week for six weeks.

For the treatment of viral hepatitis A, 125 mg of the drug is prescribed twice a day, after which you need to take 125 mg of the drug every other day. The total dose per course is 1.25 g.

For the treatment of hepatitis B in acute form, a dose of 125 mg of drugs is prescribed in the first two days, then 125 mg every other day. The total dose per course is 2 g. If the disease is protracted, then the total dose per course is 2.5 g (that is, 20 tablets)

If a patient is diagnosed with chronic hepatitis B, he is prescribed 250 mg in the first 2 days, then 125 mg every other day. The total dose of Lavomax per course is 3.75-5 g. The duration of therapy can be up to 6 months. In this case, the doctor takes into account the results of laboratory tests that characterize the activity of the pathological process in the patient.

For hepatitis C, 125 mg of Lavomax is prescribed in the first 2 days, then 125 mg every other day. The total dose per course is 2.5 g. In the case of chronic hepatitis C, 250 mg is prescribed in the first two days, then 125 mg every other day. The total dose per course is 5 g. The duration of administration is determined by the doctor, taking into account laboratory parameters. Therapy can last up to 6 months.

When treating cytomegalovirus or herpetic infections, 125 mg of Lavomax is prescribed in the first 2 days, then in the same dose every other day. The total dose per course is 2.5 g. Treatment of genital herpes involves a similar dosage regimen.

Patients with non-gonococcal urethritis, respiratory and urogenital chlamydia are prescribed 125 mg in the first 2 days, then in the same dose every other day. The total dose per course is 1.25 g.

The complex treatment of pulmonary tuberculosis includes taking 250 mg of Lavomax in the first 2 days, then 125 mg every other day. The dose per course is 2.5 g.

In the complex treatment of neuroviral infections, the dosage is determined by the doctor on an individual basis. Treatment lasts 4 weeks.

Overdose

There have been no recorded cases of Lavomax overdose.

Interaction

No clinically significant interaction of Lavomax with other drugs, in particular antibiotics, has been determined, which is why the tablets can be taken together with antibacterial agents and other drugs that are used in the treatment of bacterial and viral diseases.

Terms of sale

Lavomax can be purchased without a prescription.

Storage conditions

Store at temperatures up to 25°C. It is necessary to protect the tablets from exposure to moisture and light, and keep them away from children.

Best before date

The shelf life of Lavomax tablets is 2 years.

special instructions

Does not affect the ability to drive vehicles or operate dangerous machinery.

Patients interested in whether Lavomax is an antibiotic or not should note that the drug has an exclusively antiviral effect.

Lavomax's analogues

Those who are interested in whether cheaper analogs of Lavomax are available for sale should know about the existence of drugs with a similar effect, such as Amiksin, Tiloron. These drugs are produced by Russian pharmaceutical companies, so their cost is lower.

Also, Actaviron, Tiloram and Tilaxin have a similar effect on the body.

Alcohol and Lavomax

Drinking alcohol during treatment is not recommended, since combining medication and ethanol can lead to the development of asthenia and a serious deterioration in well-being. The development of allergic manifestations is also possible. In addition, with this combination the effect on the functions of the immune system will be extremely negative.

For children

Lavomax is not prescribed to patients under 18 years of age.

During pregnancy and lactation

Treatment with Lavomax is contraindicated both during pregnancy and during breastfeeding.

Reviews of Lavomax

There are varied reviews about Lavomax on the forums. Many users write about the tablets as an effective means for preventing colds and flu. It is also noted that the tablets act in the treatment of viral diseases, allowing you to quickly get rid of unpleasant symptoms. Reviews from doctors about Lavomax indicate that the drug is more effective as part of a complex treatment.

Lavomax price, where to buy

How much the medicine costs depends on the packaging of the drug. The price of Lavomax tablets (6 pieces) ranges from 610 to 700 rubles. Packaging cost is 10 pcs. -rub.

The price of Lavomax in Ukraine (Nikolaev, Kharkov, etc.) is hryvnia per pack of 3 pcs. Buy medicine in a package of 10 pcs. in Odessa and other cities you can get it for a price starting from 370 hryvnia.

  • Online pharmacies in Russia Russia
  • Online pharmacies in Ukraine Ukraine
  • Online pharmacies in Kazakhstan Kazakhstan

WER.RU

ZdravZone

Pharmacy IFC

Pharmacy24

PaniPharmacy

BIOSPHERE

Education: Graduated from Rivne State Basic Medical College with a degree in Pharmacy. Graduated from Vinnitsa State Medical University named after. M.I. Pirogov and internship at his base.

Work experience: From 2003 to 2013 – worked as a pharmacist and manager of a pharmacy kiosk. She was awarded diplomas and decorations for many years of conscientious work. Articles on medical topics were published in local publications (newspapers) and on various Internet portals.

Inna: Usually, insomnia occurs for me due to some kind of experience and when you lie down, it’s not.

Olesya: I tried glycine forte, which is more expensive in the price category, but the dosage is the same.

Andrey: Not a word is said about choosing the size of stockings according to a person’s parameters: height, leg size, etc.

Olga: For coxarthrosis of the 2nd degree, I have been injecting for 4 years at the rate (after 6 months), there is no improvement.

All materials presented on the site are for reference and informational purposes only and cannot be considered a treatment method prescribed by a doctor or sufficient advice.

The site administration and the authors of the articles are not responsible for any losses and consequences that may arise when using the site materials.

Source: http://medside.ru/lavomaks

LAVOMAX

◊ Tablets, yellow to orange, round; The core of the tablet is orange.

Excipients: magnesium hydroxycarbonate (heavy magnesium carbonate) - 69 mg, povidone Kmg, calcium stearate - 2 mg.

Shell composition: sucrose - 158.11 mg, povidone K17 - 5.65 mg, copovidone - 0.44 mg, magnesium hydroxycarbonate (light magnesium carbonate) - 25.7 mg, titanium dioxide - 1.2 mg, colloidal silicon dioxide (Aerosil A-380) - 1 mg, dye quinoline yellow - 0.09 mg, sunset yellow dye - 0.01 mg, macrogolmg, beeswax - 0.15 mg, liquid paraffin - 0.15 mg, talc - 1.5 mg.

3 pcs. — cellular contour packages (1) — cardboard packs.

3 pcs. — contour cell packaging (2) — cardboard packs.

4 things. — cellular contour packages (1) — cardboard packs.

4 things. — contour cell packaging (2) — cardboard packs.

6 pcs. — cellular contour packages (1) — cardboard packs.

6 pcs. — contour cell packaging (2) — cardboard packs.

10 pieces. — cellular contour packages (1) — cardboard packs.

10 pieces. — contour cell packaging (2) — cardboard packs.

Antiviral and immunomodulatory drug. Lavomax stimulates the formation of α-, β-, γ-interferons in the body. In response to Lavomax administration, interferon is produced mainly by intestinal epithelial cells, hepatocytes, T-lymphocytes and neutrophils.

After taking the drug orally, the maximum production of interferon is determined in the sequence intestine-liver-blood after 4-24 hours. Lavomax has an immunomodulatory and antiviral effect. Stimulates bone marrow stem cells, depending on the dose, enhances antibody formation, reduces the degree of immunosuppression, restores the T-helper/T-suppressor ratio.

Effective against various viral infections, incl. against influenza viruses, other acute respiratory viral infections, hepatitis and herpes viruses, cytomegaloviruses and neurotropic viruses.

The mechanism of antiviral action is associated with inhibition of the translation of virus-specific proteins in infected cells, as a result of which viral reproduction is suppressed.

After taking the drug orally, tilorone is quickly absorbed from the gastrointestinal tract. Bioavailability is 60%.

Binding to blood plasma proteins is about 80%.

Metabolism and excretion

Tiloron does not undergo biotransformation and does not accumulate in the body. It is excreted almost unchanged in feces (about 70%) and urine (about 9%). T 1/2 is 48 hours.

The drug is used in adults as part of complex therapy:

— infectious-allergic and viral encephalomyelitis;

- urogenital and respiratory chlamydia;

Treatment and prevention of influenza and other acute respiratory viral infections.

- lactation period (breastfeeding);

- children and adolescents up to 18 years of age;

- sucrase/isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption (the drug contains sucrose);

- hypersensitivity to the components of the drug.

The drug is taken orally after meals.

When treating influenza and other acute respiratory viral infections - in the first two days of the disease - 125 mg, then - 125 mg every other day. Course dose of mg (per course of treatment - 6 tablets of 125 mg each).

For the prevention of influenza and other acute respiratory viral infections - 125 mg once a week for 6 weeks. For a course of treatment - 6 tablets. 125 mg each.

For the treatment of viral hepatitis A - the first day, 125 mg 2 times, then 125 mg every other day. The course dose is 1.25 g (per course of treatment - 10 tablets of 125 mg each).

For the treatment of acute hepatitis B - 125 mg on the first and second days, then 125 mg every other day. The course dose is 2 g (per course of treatment - 16 tablets of 125 mg each), for protracted hepatitis Vmg 2 times a day on the first day, then 125 mg every other day. The course dose is 2.5 g (per course of treatment - 20 tablets of 125 mg each).

For chronic hepatitis B - the initial phase of treatment (2.5 g) - the first two days, 250 mg, then 125 mg every other day. Continuation phase (from 1.25 g to 2.5 g) - 125 mg per week. The course dose of the drug Lavomax is from 3.75 to 5 g (per course of treatment - from 30 to 40 tablets of 125 mg), the duration of therapy is 3.5-6 months, depending on the results of biochemical, immunological, morphological studies, reflecting the degree of activity of the process.

For acute hepatitis C - 125 mg on the first and second days, then 125 mg every other day. The course dose is 2.5 g (per course of treatment - 20 tablets of 125 mg each).

For chronic hepatitis C - the initial phase of treatment (2.5 g) - the first two days, 250 mg, then every other day. Continuation phase (2.5 g) - 125 mg per week. The course dose of the drug Lavomax is 5 g (per course of treatment - 40 tablets of 125 mg each). The duration of therapy is 6 months, depending on the results of biochemical, immunological, and morphological markers of the activity of the process.

For the treatment of herpetic and cytomegalovirus infections - the first two days, 125 mg, then every other day, 125 mg. The course dose is 2.5 g (per course of treatment - 20 tablets of 125 mg each).

For urogenital and respiratory chlamydia, non-gonococcal urethritis - the first two days, 125 mg, then every other day, 125 mg. The course dose is 1.25 g (per course of treatment - 10 tablets of 125 mg each).

As part of complex therapy for pulmonary tuberculosis - 250 mg for the first two days, then 125 mg every other day. The course dose is 2.5 g (per course of treatment - 20 tablets of 125 mg each).

As part of complex therapy for neuroviral infections, the dose is set individually, the course of treatment is 4 weeks.

Possible: short-term chills, allergic reactions, symptoms of dyspepsia.

There are no known cases of overdose of Lavomax.

No clinically significant interaction of the drug Lavomax with antibiotics, standard therapy for viral and bacterial diseases, or alcohol has been identified.

Compatible with antibiotics and standard therapy for viral and bacterial diseases.

Impact on the ability to drive vehicles and operate machinery

The use of the drug does not affect the ability to drive vehicles or engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

Contraindicated in children and adolescents under 18 years of age.

The drug should be stored out of the reach of children, in a dry, dark place at a temperature not exceeding 25°C. Shelf life: 2 years.

To ask a question about the project or contact the editors, use this form.

Source: http://health.mail.ru/drug/lavomax/

Lavomax - official instructions for use

on medical use of the drug

Registration number

Trade name of the drug

International nonproprietary name

Dosage form

film-coated tablets

Compound

One tablet contains:

core: active ingredient – ​​tilorone dihydrochloride – 125 mg; excipients: magnesium hydroxycarbonate (heavy magnesium carbonate) – 69 mg, povidone K30 – 4 mg, calcium stearate – 2 mg;

shell: sucrose – 158.11 mg, povidone K17 – 5.65 mg, copovidone – 0.44 mg, magnesium hydroxycarbonate (light magnesium carbonate) – 25.7 mg, titanium dioxide – 1.2 mg, colloidal silicon dioxide (aerosil A-380) 1 mg, quinoline yellow dye - 0.09 mg, sunset yellow dye 0.01 mg, macrogol-6000 - 6 mg, beeswax - 0.15 mg, liquid paraffin -0.15 mg, talc - 1.5 mg.

Film-coated tablets, yellow to orange in color, round in shape. The core of the tablet is orange.

Pharmacotherapeutic group

Antiviral immunostimulating agent – ​​inducer of interferon formation

Pharmacological properties

Tilorone stimulates the formation of alpha, beta, gamma and lambda interferons in the body. The main producers of interferon in response to the administration of tilorone are intestinal epithelial cells and hepatocytes. T lymphocytes, neutrophils and granulocytes. After oral administration, the maximum production of interferon is determined in the sequence intestine - liver - blood after 4-24 hours.

Tiloron has an immunomodulatory and antiviral effect. Induces the synthesis of interferon in human leukocytes. Stimulates bone marrow stem cells, enhances antibody formation, reduces the degree of immunosuppression, restores the T-helper/T-suppressor ratio. Effective against various viral infections, including influenza viruses, other acute respiratory viral infections, hepatitis viruses and herpes viruses.

The mechanism of antiviral action is associated with inhibition of the translation of virus-specific proteins in infected cells, as a result of which viral reproduction is suppressed.

After oral administration, Tilorone is rapidly absorbed from the gastrointestinal tract. Bioavailability is 60%. About 80% of tilorone is bound to plasma proteins. Tilorone is excreted almost unchanged through the intestines (70%) and through the kidneys (9%). The half-life is 48 hours. Tiloron does not undergo biotransformation and does not accumulate in the body.

Indications for use

— treatment and prevention of influenza and other acute respiratory viral infections;

- as part of complex therapy for herpes infection, cytomegalovirus infection;

- as part of complex therapy of urogenital and respiratory chlamydia. in complex therapy of non-gonococcal urethritis;

— as part of complex therapy for viral hepatitis A, B, C;

— as part of complex therapy of pulmonary tuberculosis;

- as part of complex therapy of infectious-allergic and viral encephalomyelitis.

Contraindications

Hypersensitivity to the drug.

Pregnancy and lactation period.

Children's age (up to 18 years).

Sucrase/isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption (the drug contains sucrose).

Directions for use and doses

The drug is taken orally after meals.

When treating influenza and other acute respiratory viral infections - in the first two days of illness, 125 mg, then after 48 hours, 125 mg. The course dose is 750 mg (per course of treatment – ​​6 tablets of 125 mg each).

For the prevention of influenza and other acute respiratory viral infections - 125 mg once a week for 6 weeks (per course of treatment - 6 tablets of 125 mg).

For the treatment of herpetic cytomegalovirus infection - the first two days, 125 mg, then after 48 hours, 125 mg. The course dose is 1.25-2.5 g (per course of treatment – ​​125 mg tablets).

For urogenital and respiratory chlamydia, non-gonococcal urethritis - the first two days, 125 mg, then after 48 hours, 125 mg. The course dose is 1.25 g (per course of treatment - 10 tablets of 125 mg each).

For the treatment of viral hepatitis A - the first day, 125 mg 2 times, then 125 mg every 48 hours. The course dose is 1.25 g (per course of treatment - 10 tablets of 125 mg each).

For the treatment of acute hepatitis B - 125 mg on the first and second days, then 125 mg every 48 hours. The course dose is 2 g (per course of treatment - 16 tablets of 125 mg), for prolonged hepatitis B - 125 mg 2 times a day on the first day, then 125 mg after 48 hours. The course dose is 2.5 g (per course of treatment - 20 tablets of 125 mg each).

For chronic hepatitis B - the initial phase of treatment (2.5 g) - the first two days, 125 mg 2 times a day, then 125 mg after 48 hours. Continuation phase (from 1.25 g to 2.5 g) – 125 mg per week. The course dose of Lavomax ® is from 3.75 to 5 g (per course of treatment - from 30 to 40 tablets of 125 mg), duration of therapy is 3.5-6 months, depending on the results of biochemical, immunological, morphological studies, reflecting the degree of activity of the process.

For acute hepatitis C - the first and second days, 125 mg, then 125 mg after 48 hours. The course dose is 2.5 g (per course of treatment - 20 tablets of 125 mg each).

For chronic hepatitis C - the initial phase of treatment (2.5 g) - the first two days, 125 mg 2 times a day, then 125 mg after 48 hours. Continuation phase (2.5 g) – 125 mg per week. The course dose of Lavomax ® is 5 g (per course of treatment - 40 tablets of 125 mg), duration of therapy - 6 months, depending on the results of biochemical, immunological, morphological markers of the activity of the process.

As part of complex therapy for pulmonary tuberculosis - 250 mg for the first two days, then 125 mg after 48 hours. The course dose is 2.5 g (per course of treatment - 20 tablets of 125 mg each).

As part of complex therapy for infectious-allergic and viral encephalomyelitis - pomg per day for the first 2 days of treatment, then 125 mg after 48 hours. The dose is set individually, the course of treatment is 3-4 weeks.

Side effect

Allergic reactions, dyspepsia, short-term chills are possible.

Overdose

There are no known cases of Lavomax ® overdose.

Interaction with other drugs

Compatible with antibiotics and standard therapy for viral and bacterial diseases.

No clinically significant interaction of Lavomax ® with antibiotics, standard therapy for viral and bacterial diseases, or alcohol has been identified.

Impact on the ability to drive vehicles and operate machinery

The use of the drug does not affect the ability to drive vehicles or engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

Release form

Film-coated tablets, 125 mg.

3, 4, 6 or 10 tablets per blister pack. One or two blister packs along with instructions for use of the medicinal product are placed in a cardboard pack.

Storage conditions

In a dry place, protected from light, at a temperature not exceeding 25 ° C.

Keep out of the reach of children.

Best before date

2 years. Do not use the drug after the expiration date indicated on the package.

Conditions for dispensing from pharmacies

Manufacturer/organization accepting claims

JSC Nizhpharm, Russia

603950, Nizhny Novgorod, GSP-459, st. Salganskaya, 7

Source: http://medi.ru/instrukciya/lavomaks_2704/

Lavomax: instructions for use

The drug Lavomax is a stimulator of interferon production in the body and belongs to the group of antiviral immunomodulatory agents.

Release form and composition of the medicinal product

Lavomax is available in the form of tablets for oral use, coated with an orange or yellow protective coating. The drug is packaged in blisters of 3, 4, 6 or 10 pieces in a cardboard box, which also includes detailed instructions with a description.

The main active ingredient of the drug is Tilorone dihydrochloride, each tablet contains 125 mg of this component. In addition to the active substance, the drug contains chemical auxiliary components.

Pharmacological properties

Lavomax is an immunostimulating and antiviral agent. When the drug enters the gastrointestinal tract, Tiloron dihydrochloride is absorbed by the walls of the small intestine into the systemic bloodstream, after which the body begins to increase the production of interferons under the influence of this drug.

The maximum production of interferons while taking the drug is observed after 4 hours. Lavomax stimulates the work of bone marrow stem cells and enhances the formation of antibodies. The drug is highly effective against many pathogens of viral infections, including influenza viruses, parainfluenza, acute respiratory diseases, hepatitis viruses, cytomegalovirus, and herpetic infections.

The active ingredient of the drug penetrates directly into the cell damaged by the virus, blocking its reproduction at the DNA level.

Indications for use

The drug Lavomax is prescribed to patients as a primary, auxiliary or prophylactic agent for the following conditions:

  • Cytomegalovirus infection;
  • Herpetic rashes on the skin and mucous membranes;
  • Hepatitis B, C and A;
  • Viral encephalomyelitis;
  • Urethritis is not of gonococcal origin;
  • Urogenital chlamydial infection;
  • Pulmonary tuberculosis;
  • Treatment and prevention of acute respiratory diseases and influenza, parainfluenza, adviral infection.

Contraindications

In some situations, the use of Lavomax for the treatment and prevention of viral infections is prohibited. Contraindications include:

  • Individual hypersensitivity or intolerance to the main active ingredient;
  • The period of pregnancy and breastfeeding;
  • Patients under 18 years of age due to the lack of clinical experience and data on the safety of use in pediatric practice;

Since the drug contains sucrose, Lavomax tablets are contraindicated in patients with a deficiency of sucrose and isomaltose in the body.

Method of administration and dosage regimen of the drug

Tablets are prescribed to patients orally before meals. The dose of the drug depends on the indications.

For the treatment of influenza and acute respiratory viral infections, the drug should be taken as soon as possible, optimally on the day the first clinical symptoms appear. The tablet is taken once a day, and after 2 days from the start of therapy it is enough to take the medicine once every other day. The course of treatment is determined by a specialist.

To prevent influenza and viral infections during epidemic outbreaks, the patient is prescribed 1 tablet of the drug once a week for 1.5 months.

For the treatment of viral hepatitis, the drug is first taken once a day, one tablet, then every other day. The duration of treatment is determined by the doctor depending on the severity of the disease and the individual characteristics of the body.

For the treatment of chronic hepatitis B, in the first 2 days the patient is prescribed 1 tablet 2 times a day, then 1 tablet every other day. The course of treatment is at least 4 months.

As part of the complex treatment of pulmonary tuberculosis, in the first 2 days the patient is prescribed 1 tablet 2 times a day, then 1 tablet every other day. The duration of treatment is determined by a specialist individually.

Use of the product during pregnancy and lactation

The effectiveness and safety of the influence of the main active component of the drug Lavomax on the woman’s body and the intrauterine development of the fetus have not been established, therefore this drug is contraindicated while expecting a child.

It is not known whether the drug is excreted in breast milk, therefore Lavomax therapy is not recommended during lactation. If treatment is necessary, breastfeeding should be stopped so as not to harm the baby.

Adverse reactions

If the doses recommended in the instructions are followed, the drug is well tolerated by patients, however, persons with increased individual sensitivity during therapy noted the development of the following adverse reactions:

  • Increased flu-like symptoms - muscle pain, fever, lethargy, weakness, body aches;
  • Allergic skin rashes, urticaria;
  • Stomach pain, dyspeptic symptoms (diarrhea, nausea, vomiting);
  • Chills.

Overdose

Cases of overdose with Lavomax have not been described if the therapeutic dose indicated in the instructions is followed. If a large dose of the drug is accidentally administered orally, the above-described side effects may increase. In this case, treatment with the drug is canceled, and the patient is induced to vomit, after which he is allowed to take enterosorbents.

Interaction with other drugs

Lavomax is compatible with antibiotics and any other medications.

It is not recommended to drink alcohol or take medicinal tinctures containing alcohol during therapy.

special instructions

The active ingredient of the tablets does not affect the functioning of the central nervous system and does not inhibit the speed of psychomotor reactions.

The drug is not used to treat children and adolescents under 18 years of age, since the safety of the effect of the active substance on the body has not been established.

Analogs of Lavomax tablets

The following drugs are similar in their therapeutic effect to the drug Lavomax:

  • Amiksin tablets;
  • Tilarone tablets;
  • Amizon;
  • Amizon max tablets;
  • Tylaxin tablets.

Before replacing the drug with one of these analogues, you should check with your doctor about the dose and indications, since not all of the drugs listed are effective for chlamydia and other pathologies for which Lavomax is effective.

Storage and release conditions

The drug can be purchased in pharmacies freely, without a doctor's prescription. It is recommended to keep the tablets away from children in a cool place, avoiding exposure of the drug to sunlight. The expiration date of the medicine is indicated on the packaging, after which the tablets cannot be taken orally.

Lavomax price

The approximate cost of the drug Lavomax in Moscow pharmacies is 535 rubles.

Source: http://bezboleznej.ru/lavomaks

Lavomax ® (Lavomax)

Active substance:

Content

Pharmacological groups

Nosological classification (ICD-10)

3D images

Compound

Description of the dosage form

Film-coated tablets: yellow to orange, round in shape. The core of the tablet is orange.

pharmachologic effect

Pharmacodynamics

Tilorone stimulates the formation of α-, β-, γ- and λ-interferons in the body. The main producers of interferon in response to the administration of tilorone are intestinal epithelial cells, hepatocytes, T-lymphocytes, neutrophils and granulocytes. After oral administration, the maximum production of interferon is determined in the intestine-liver-blood sequence after 4–24 hours. Tiloron has an immunomodulatory and antiviral effect. Induces the synthesis of interferon in human leukocytes. Stimulates bone marrow stem cells, enhances antibody formation, reduces the degree of immunosuppression, restores the T-helper/T-suppressor ratio. Effective against various viral infections, incl. influenza viruses, other acute respiratory viral infections, hepatitis viruses and herpes viruses. The mechanism of antiviral action is associated with inhibition of the translation of virus-specific proteins in infected cells, as a result of which viral reproduction is suppressed.

Pharmacokinetics

After oral administration, Tilorone is rapidly absorbed from the gastrointestinal tract. Bioavailability is 60%. About 80% of tilorone is bound to plasma proteins. Tilorone is excreted almost unchanged through the intestines (70%) and kidneys (9%). T1 /2 is 48 hours. Tiloron does not undergo biotransformation and does not accumulate in the body.

Indications of the drug Lavomax ®

As part of complex therapy in adults:

treatment of influenza and other acute respiratory viral infections;

treatment of herpes infection.

Prevention of influenza and other acute respiratory viral infections in adults.

Contraindications

hypersensitivity to the drug or other components of the drug;

sucrase/isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption (the drug contains sucrose);

children under 18 years of age.

Side effects

Allergic reactions, dyspeptic symptoms, and short-term chills are possible.

If any of the side effects indicated in the description worsen or the patient notices any other side effects not listed in the description, the doctor should be informed.

Interaction

Compatible with antibiotics and traditional treatments for viral and bacterial diseases.

No clinically significant interaction of the drug Lavomax ® with antibiotics, traditional treatments for viral and bacterial diseases, or alcohol has been identified.

Directions for use and doses

Inside, after eating.

When treating influenza and other acute respiratory viral infections: in the first 2 days of illness, 125 mg, then after 48 hours, 125 mg. Per course - 750 mg (6 tablets).

For the prevention of influenza and other acute respiratory viral infections: 125 mg once a week for 6 weeks. Per course - 750 mg (6 tablets).

For the treatment of herpes infection: the first 2 days, 125 mg, then after 48 hours, 125 mg. The course dose is 1.25-2.5 g (per course of treatment - 10-20 tablets).

When treating influenza and other acute respiratory viral infections, if symptoms of the disease persist for more than 4 days, you should consult a doctor.

Overdose

Cases of overdose are unknown.

special instructions

Impact on the ability to drive vehicles and operate machinery. The use of the drug does not affect the ability to drive vehicles or engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

Release form

Film-coated tablets, 125 mg. 3, 4, 6 or 10 tablets. in blister packs. 1 or 2 blister packs are placed in a cardboard pack.

Manufacturer

JSC "Nizhpharm"., Russia, Nizhny Novgorod, GSP-459, Salganskaya, 7.

Tel.: ; Fax: .

Organization receiving claims: Nizhpharm JSC, Russia.

Conditions for dispensing from pharmacies

Storage conditions for the drug Lavomax ®

Keep out of the reach of children.

Shelf life of Lavomax ®

Do not use after the expiration date stated on the package.

Synonyms of nosological groups

Prices in Moscow pharmacies

The information is intended solely for comparing prices in stationary pharmacies operating in accordance with Article 55 of the Federal Law “On the Circulation of Medicines” dated April 12, 2010 N 61-FZ.

film-coated tablets 125 mg, 3 pcs.

NIZHFARM OJSC (Russia)

film-coated tablets 125 mg, 6 pcs.

NIZHFARM OJSC (Russia)

film-coated tablets 125 mg, 10 pcs.

NIZHFARM JSC (Russia)

film-coated tablets 125 mg, 10 pcs.

NIZHFARM OJSC (Russia)

film-coated tablets 125 mg, 6 pcs.

NIZHFARM JSC (Russia)

Reviews

Leave your comment

Current information demand index, ‰

Opinion of “Doctors of the Russian Federation” about the drug Lavomax ®

Registered prices of vital and essential drugs

  • First aid kit
  • Online store
  • About company
  • Contacts
  • Publisher contacts:
  • Email:
  • Address: Russia, Moscow, st. 5th Magistralnaya, no. 12.

When quoting information materials published on the pages of the website www.rlsnet.ru, a link to the source of information is required.

©. REGISTER OF MEDICINES OF RUSSIA ® RLS ®

All rights reserved

Commercial use of materials is not permitted

Information intended for healthcare professionals

Source: http://www.rlsnet.ru/tn_index_id_29601.htm

Lavomax ®

Yellow to orange film-coated tablets The core of the tablet is orange.

Excipients: magnesium hydroxycarbonate (heavy magnesium carbonate) - 69 mg, povidone Kmg, calcium stearate - 2 mg.

Shell composition: sucrose - 158.11 mg, povidone K17 - 5.65 mg, copovidone - 0.44 mg, magnesium hydroxycarbonate (light magnesium carbonate) - 25.7 mg, titanium dioxide - 1.2 mg, colloidal silicon dioxide (Aerosil A-380) - 1 mg, dye quinoline yellow - 0.09 mg, sunset yellow dye - 0.01 mg, macrogolmg, beeswax - 0.15 mg, liquid paraffin - 0.15 mg, talc - 1.5 mg.

3 pcs. — cellular contour packages (1) — cardboard packs.

3 pcs. — contour cell packaging (2) — cardboard packs.

4 things. — cellular contour packages (1) — cardboard packs.

6 pcs. — cellular contour packages (1) — cardboard packs.

6 pcs. — contour cell packaging (2) — cardboard packs.

10 pieces. — cellular contour packages (1) — cardboard packs.

10 pieces. — contour cell packaging (2) — cardboard packs.

Antiviral and immunomodulatory drug. Lavomax ® stimulates the formation of α-, β-, γ-interferons in the body. In response to Lavomax administration, interferon is produced mainly by intestinal epithelial cells, hepatocytes, T-lymphocytes and neutrophils.

After taking the drug orally, the maximum production of interferon is determined in the sequence intestine-liver-blood after 4-24 hours. Lavomax ® has an immunomodulatory and antiviral effect. Stimulates bone marrow stem cells, depending on the dose, enhances antibody formation, reduces the degree of immunosuppression, restores the T-helper/T-suppressor ratio.

Effective against various viral infections, incl. against influenza viruses, other acute respiratory viral infections, hepatitis and herpes viruses, cytomegaloviruses and neurotropic viruses.

The mechanism of antiviral action is associated with inhibition of the translation of virus-specific proteins in infected cells, as a result of which viral reproduction is suppressed.

After taking the drug orally, tilorone is quickly absorbed from the gastrointestinal tract. Bioavailability is 60%.

Binding to blood plasma proteins is about 80%.

Metabolism and excretion

Tiloron does not undergo biotransformation and does not accumulate in the body. It is excreted almost unchanged in feces (about 70%) and urine (about 9%). T 1/2 is 48 hours.

The drug is used in adults as part of complex therapy:

— viral hepatitis A, B and C;

— infectious-allergic and viral encephalomyelitis;

- urogenital and respiratory chlamydia;

Treatment and prevention of influenza and other acute respiratory viral infections.

The drug is taken orally after meals.

When treating influenza and other acute respiratory viral infections - in the first two days of the disease - 125 mg, then - 125 mg every other day. Course dose of mg (per course of treatment - 6 tablets of 125 mg each).

For the prevention of influenza and other acute respiratory viral infections - 125 mg once a week for 6 weeks. For a course of treatment - 6 tablets. 125 mg each.

For the treatment of viral hepatitis A - the first day, 125 mg 2 times, then 125 mg every other day. The course dose is 1.25 g (per course of treatment - 10 tablets of 125 mg each).

For the treatment of acute hepatitis B - 125 mg on the first and second days, then 125 mg every other day. The course dose is 2 g (per course of treatment - 16 tablets of 125 mg each), for protracted hepatitis Vmg 2 times a day on the first day, then 125 mg every other day. The course dose is 2.5 g (per course of treatment - 20 tablets of 125 mg each).

For chronic hepatitis B - the initial phase of treatment (2.5 g) - the first two days, 250 mg, then 125 mg every other day. Continuation phase (from 1.25 g to 2.5 g) - 125 mg per week. The course dose of the drug Lavomax ® is from 3.75 to 5 g (per course of treatment - from 30 to 40 tablets of 125 mg), the duration of therapy is 3.5-6 months, depending on the results of biochemical, immunological, morphological studies, reflecting the degree of activity of the process.

For acute hepatitis C - 125 mg on the first and second days, then 125 mg every other day. The course dose is 2.5 g (per course of treatment - 20 tablets of 125 mg each).

For chronic hepatitis C - the initial phase of treatment (2.5 g) - the first two days, 250 mg, then every other day. Continuation phase (2.5 g) - 125 mg per week. The course dose of Lavomax ® is 5 g (per course of treatment - 40 tablets of 125 mg each). The duration of therapy is 6 months, depending on the results of biochemical, immunological, and morphological markers of the activity of the process.

For the treatment of herpetic and cytomegalovirus infections - the first two days, 125 mg, then every other day, 125 mg. The course dose is 2.5 g (per course of treatment - 20 tablets of 125 mg each).

For urogenital and respiratory chlamydia, non-gonococcal urethritis - the first two days, 125 mg, then every other day, 125 mg. The course dose is 1.25 g (per course of treatment - 10 tablets of 125 mg each).

As part of complex therapy for pulmonary tuberculosis - 250 mg for the first two days, then 125 mg every other day. The course dose is 2.5 g (per course of treatment - 20 tablets of 125 mg each).

As part of complex therapy for neuroviral infections, the dose is set individually, the course of treatment is 4 weeks.

Possible: short-term chills, allergic reactions, symptoms of dyspepsia.

- lactation period (breastfeeding);

- children and adolescents up to 18 years of age;

- sucrase/isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption (the drug contains sucrose);

- hypersensitivity to the components of the drug.

Contraindicated in children and adolescents under 18 years of age.

Impact on the ability to drive vehicles and operate machinery

The use of the drug does not affect the ability to drive vehicles or engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

There are no known cases of overdose of Lavomax ®.

No clinically significant interaction of the drug Lavomax ® with antibiotics, standard therapy for viral and bacterial diseases, or alcohol has been identified.

Compatible with antibiotics and standard therapy for viral and bacterial diseases.

The drug should be stored out of the reach of children, in a dry, dark place at a temperature not exceeding 25°C. Shelf life: 2 years.

The scientific information provided is general and cannot be used to make a decision about the possibility of using a particular drug.

There are contraindications, consult your doctor.

Consultations and Information services are provided by partners.

* The cost of consultation and information services is 99 rubles for the first consultation. If the first consultation is carried out by a dermatologist or venereologist - 499 rubles. Subsequent consultations and information services cost 499 rubles. More details about the promotion. We'll refund your money if you don't like the consultation. To use the service, you must link a bank card. Money will be debited from the card only after the service has been provided.

0+ Yandex.Health is an online consultation service with doctors. To make a diagnosis and prescribe a treatment plan, you should make an appointment with a specialist.

Apple and the Apple logo are registered trademarks of Apple Inc. in the USA and other countries.

App Store is a service mark of Apple Inc.

Android, Google Play and the Google Play logo are trademarks of Google Inc.

Source: http://health.yandex.ru/pills/lavomaks-5987

What does Lavomax help with?

Lavomax is a complex antiviral and immunomodulatory drug that helps cope with various infectious and inflammatory diseases of the body.

Long-term use of this medication stimulates the body's own production of interferon, which has effective antiviral properties against many influenza viruses, herpes infections, viral hepatitis, etc.

The main active medicinal substance of Lavomax is tilorone, which has a wide spectrum of antiviral action.

Regular use of the drug promotes an immunomodulatory effect, which can significantly strengthen the body's defenses against various viral diseases for a sufficiently long period of time.

In general, this antiviral drug is quite well tolerated by many patients, without the development of serious side complications.

Main indications for use of Lavomax:

  • complex treatment and prevention of various viral diseases;
  • influenza or ARVI;
  • viral hepatitis A, B, C;
  • herpetic infection;
  • complex treatment of multiple sclerosis;
  • cytomegalovirus infection;
  • urogenital or respiratory chlamydia.

Attention: before starting to use Lavomax, it is recommended to consult with a qualified general practitioner!

The drug is available in the form of soluble tablets for internal use.

How to drink Lavomax?

For adults and children over 12 years of age, the daily dose of Lavomax for the treatment of influenza and ARVI, in the first 2 days of illness, is 1 t after meals, washed down with plenty of liquid, and then 1 t every 48 hours for days.

To prevent colds and flu, this antiviral drug is recommended to be taken 1 t. 1 r. per week for 1-2 months.

For complex treatment of viral hepatitis, the daily dose on the first day is 1 t. 1-2 r. after meals, and then 1 t. every 48 hours.

In order to prevent the possible development of viral hepatitis, Lavomax is recommended to drink 1 t. (0.125 mg.) 1 r. per week for a month.

The course of treatment and dose of the drug is determined by the attending physician absolutely individually for each patient, depending on the severity of the particular disease.

For the treatment of herpetic infection, Lavomax is prescribed 1 t (0.125 mg) in the first 2 days, and then every 48 hours, 1 t after meals, with a sufficient amount of water. The minimum course of treatment is 7-10 days.

Contraindications to the use of Lavomax

  • hypersensitivity (increased sensitivity of the body to the main active ingredients of the drug);
  • age up to 12 years;
  • pregnancy and lactation (breastfeeding).

Side effects of Lavomax

As a rule, this drug is well tolerated by many patients, but the following minor adverse reactions may occur extremely rarely:

  • digestive system disorders (diarrhea, constipation);
  • short-term chills;
  • nausea (noted with a significant overdose of the drug);
  • allergic manifestations (urticaria, increased skin itching).

If any adverse reactions develop after long-term use of this medication, it is recommended to consult with your doctor!

In this article, we looked at what Lavomax helps with, as well as how to take it correctly.

Read also:

Share on social networks

Add a comment

Categories:

Advertising

Good to know:

Join us!

Let's improve the site!

Remember, self-medication is dangerous to your health! Consult your doctor

Source: http://in4health.ru/ot-chego-pomogaet-lavomaks.html